Phathom Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Other eventsSep 29 →InsidersNo open-market buys. 1 insider sold $7,079 in 1 sale, with no 10b5-1 plan named.→HoldersFrazier Life Sciences 15.6%Medicxi Ventures Management (Jersey) 9.3%BlackRock 5.7%→Financing →PeersClosest companies: NUVB, CHRS, XERS→
From the filings
Figures
- Revenue
- $239.7Mlast 12 months
- Net income
- $122.0Mlast 12 months
- Operating cash flow
- −$97.5Mlast 12 months
- Cash and equivalents
- $182.5Mat the last balance sheet
- Total debt
- $164.6Mat the last balance sheet
- Shares outstanding
- 80.1M shareson issue